NOT-AI-09-031: AMENDMENT: Recovery Act Limited Competition for NIH Grants: Research and Research Infrastructure Grand Opportunities (RC2)

AMENDMENT: Recovery Act Limited Competition for NIH Grants: Research and Research Infrastructure Grand Opportunities (RC2)

Notice Number: NOT-AI-09-031

Key Dates
Release Date: April 22, 2009
Letters of Intent Receipt Date(s): April 27, 2009
Receipt Date: May 27, 2009
Earliest Anticipated Start Date: September 30, 2009
Expiration Date: May 28, 2009

Issued by
National Institute of Allergy and Infectious Diseases (NIAID) (www.niaid.nih.gov)

Purpose

This Notice is to inform applicants that the National Institute of Allergy and Infectious Diseases (NIAID) will participate in funding opportunity announcement RFA-OD-09-004, entitled Recovery Act Limited Competition for NIH Grants: Research and Research Infrastructure , and accept applications in the following areas:

Medical countermeasures to restore gastrointestinal function after radiation exposure due to radiological or nuclear terrorist attacks (for background information, please see http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-07-013.html)
Radionuclide decorporation agents for radiation/nuclear emergencies (for background information, please see http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-06-030.html)

To obtain additional, IC-specific information on this FOA, we strongly encourage you to visit our website at http://www.niaid.nih.gov/ncn/recovery/go.htm and /or contact the appropriate Program Officer listed below. A submission that is not directly responsive to the NIAID funding priorities will not be considered for funding.

All other aspects of this FOA remain unchanged.

Inquiries

For scientific/research inquiries to the NIAID, contact:

Medical countermeasures to restore gastrointestinal function after radiation exposure:

Dr. Andrea DiCarlo-Cohen, PhD
Division of Allergy, Immunology and Transplantation
National Institute of Allergy and Infectious Diseases, NIH
6610 Rockledge Drive, Room 1114
Bethesda, MD 20892
Telephone: (301) 451-9199
Fax: (301) 480-6597
Email: [email protected]

Radionuclide decorporation agents for radiation/nuclear emergencies:

Dr. Bert Maidment, PhD
Division of Allergy, Immunology and Transplantation
National Institute of Allergy and Infectious Diseases, NIH
6610 Rockledge Drive, Room 1113
Bethesda, MD 20892
Telephone: (301) 451-9199
Fax: (301) 480-6597
Email: [email protected]

Peer Review and Letter of Intent Contact

Dr. Priti Mehrotra, Ph.D.
Division of Extramural Activities
National Institute of Allergy and Infectious Diseases, NIH
6700B Rockledge, Drive, Room 3138
Bethesda, MD 20892-7616
Telephone: (301) 435-9369
Fax: (301) 480-2310
Email: [email protected]